WI
RPRX icon

WBI Investments’s Royalty Pharma RPRX Stock Holding History

WBI Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Buy
+5,857
New +$257K 0.08% 246
2025
Q4 		– Sell
-54,266
Closed -$1.91M – 377
2025
Q3 		$1.91M Buy
+54,266
New +$1.96M 0.49% 49

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

WBI Investments's RPRX Position: Q1 2026 in Review

WBI Investments opened a new position in Royalty Pharma (RPRX) in Q1 2026: 5,857 shares worth $281K. The stake represents 0.08% of the portfolio and ranks #246 among its holdings. This is a return to the name: WBI Investments previously reported a position in RPRX as recently as Q3 2025.

WBI Investments first reported a position in RPRX in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.91M in Q3 2025. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • WBI Investments held 5,857 shares of Royalty Pharma worth $281K as of Q1 2026.
  • Royalty Pharma was a new WBI Investments position in Q1 2026.
  • Royalty Pharma made up 0.08% of WBI Investments's portfolio in Q1 2026, its #246 holding.
  • WBI Investments first reported a position in Royalty Pharma in Q3 2025 and has held it in 2 quarters since.
  • WBI Investments's Royalty Pharma position peaked at $1.91M in Q3 2025.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.